Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

The Insight Series: AI & Digital Health with Kelly Huang

27 August 2026 · By · Wire by Fusion42

Published

27 August 2026

Topic

opportunities

◆ Sectors

Healthtech Infrastructure

◆ Source

Read at advamed.org →

◆ Verified

Fusion42 · 27 August 2026 · Fusion42 review

Kelly Huang, CEO of Elucid, discusses how AI is transforming cardiovascular diagnostics by enabling non-invasive, precise analysis of plaque biology and physiology from existing coronary CT angiograms to support personalized treatment decisions.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.

◆ ◆ The Wire takeaway

AI is moving beyond data extraction to integrate biology and physiology into heart disease diagnosis. You can use AI-powered, non-invasive tools to offer care that truly changes physician decisions and patient outcomes.

◆ Coverage

1 source · 27 Aug 2026

◆ Related on Wire

◆ Topics

Healthtech Infrastructureai-medicinedigital-healthcardiovascular-diagnosticspersonalised-carenon-invasive